万邦医药(301520.SZ)：前三季净利润3311万元 同比下降57.44%

Core Viewpoint - Wanbang Medical (301520.SZ) reported a significant decline in both revenue and net profit for the first three quarters of the year, indicating potential challenges in its business operations [1] Financial Performance - The company's operating revenue for the first three quarters was 209 million yuan, representing a year-on-year decrease of 28.60% [1] - The net profit attributable to shareholders was 33.11 million yuan, down 57.44% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 8.449 million yuan, reflecting a substantial decline of 84.89% year-on-year [1]